These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12450694)

  • 41. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL; Liu WC; Yang WW; Zhong D; Liu YH; Zhang JD; Jiang JH; Li SS
    Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites.
    Futagami S; Takahashi H; Norose Y; Kobayashi M
    Gut; 1998 Aug; 43(2):168-75. PubMed ID: 10189839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
    Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children.
    Camorlinga-Ponce M; Torres J; Perez-Perez G; Leal-Herrera Y; Gonzalez-Ortiz B; Madrazo de la Garza A; Gomez A; Muñoz O
    Am J Gastroenterol; 1998 Aug; 93(8):1264-70. PubMed ID: 9707049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta).
    Solnick JV; Canfield DR; Hansen LM; Torabian SZ
    Infect Immun; 2000 May; 68(5):2560-5. PubMed ID: 10768944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects.
    Mattsson A; Quiding-Järbrink M; Lönroth H; Hamlet A; Ahlstedt I; Svennerholm A
    Infect Immun; 1998 Jun; 66(6):2705-12. PubMed ID: 9596737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis.
    Pappo J; Thomas WD; Kabok Z; Taylor NS; Murphy JC; Fox JG
    Infect Immun; 1995 Apr; 63(4):1246-52. PubMed ID: 7890380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutralizing antibodies for Helicobacter pylori urease inhibit bacterial colonization in the murine stomach in vivo.
    Takeshita H; Watanabe E; Norose Y; Ito Y; Takahashi H
    Biomed Res; 2019; 40(2):87-95. PubMed ID: 30982804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B.
    Gu Q; Song D; Zhu M
    FEMS Immunol Med Microbiol; 2009 Aug; 56(3):197-203. PubMed ID: 19453750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
    Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.
    Lee CK; Soike K; Giannasca P; Hill J; Weltzin R; Kleanthous H; Blanchard J; Monath TP
    Vaccine; 1999 Aug; 17(23-24):3072-82. PubMed ID: 10462242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease.
    Locatelli A; Catapani WR; Gomes CR; Silva CB; Waisberg J
    World J Gastroenterol; 2004 Oct; 10(20):2997-3000. PubMed ID: 15378781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
    Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mucosal adjuvant effect of plant polysaccharides for induction of protective immunity against Helicobacter pylori infection.
    Liu C; Luo J; Xue RY; Guo L; Nie L; Li S; Ji L; Ma CJ; Chen DQ; Miao K; Zou QM; Li HB
    Vaccine; 2019 Feb; 37(8):1053-1061. PubMed ID: 30665774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
    Summerton NA; Welch RW; Bondoc L; Yang HH; Pleune B; Ramachandran N; Harris AM; Bland D; Jackson WJ; Park S; Clements JD; Nabors GS
    Vaccine; 2010 Feb; 28(5):1404-11. PubMed ID: 19897067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.
    Sijun H; Yong X
    Indian J Med Res; 2009 Aug; 130(2):115-24. PubMed ID: 19797807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.